GASTROINTESTINAL CANCER RESEARCH PROGRAM

Researchers reveal new treatment for metastatic colorectal cancer prolongs survival

According to the findings of an international clinical study published in The Lancet, the selectively targeted medication Fruquintinib resulted in a statistically significant improvement in overall survival and progression-free survival.